Plasma levels and urinary excretion of oxypurines – hypoxanthine and xanthine – were evaluated by reverse-phase high-pressure liquid chromatography in 13 patients affected by gastric tumors and in 19 colorectal tumor-bearing patients. Preliminary results indicate higher values of urinary xanthine and an increase in the xanthine/hypoxanthine ratio in cancer patients. The increase was not generalized to all subjects, and did not appear related either to the stage of the disease or to CEA values. The limits within which the determination of urinary oxypurines can be employed as a tumor marker are discussed.
Get full access to this article
View all access options for this article.
References
1.
AdamsW.S., DavisS., NokataniM.: Purine and pyrimidine excretion in normal and leukemic subjects.Am. J. Med., 28: 726–734, 1960.
2.
AleoM.F., PompucciG., D'AmatoM.S., MarcolongoR., MarinelloE.: The behavior of oxypurines in human primary gout.Quad. Sclavo Diagn., 18: 235–241, 1983.
3.
BolieuR., BoryC., BaltassatP., GonnetC.: High performance liquid chromatographic determination of hypoxanthine and xanthine in biological fluids.J. Chromatogr., 233: 131–140, 1982.
4.
BolieuR., BoryC., BaltassatP., GonnetC.: Hypoxanthine and xanthine levels determined by high performance liquid chromatography in plasma, erythrocyte and urine samples from healthy subjects: The problem of hypoxanthine level evolution as a function of time.Anal. Biochem., 129: 398–404, 1983.
5.
ChabardJ.L., Lartigue-MatteiC., VerdineF., PetitJ., BergerJ.A.: Mass-fragmentographic determination of xanthine and hypoxanthine in biological fluids.J. Chromatogr., 221: 9–17, 1980.
6.
De BreuR.A., Van BaalJ.M., De BruynC.H., BakkerenJ.A., DamSchretlenE.: High performance liquid chromatographic determination of purine and pyrimidine bases, ribonucleosides, deoxyribonucleosides and cyclic ribonucleotides in biological fluids.J. Chromatogr., 229: 67–75, 1982.
7.
HarmsenE., DeJongJ.W., SerruysP.W.: Hypoxanthine production by ischemic heart, demonstrated by high pressure liquid chromatography of blood purine, nucleosides and oxypurines.Clin. Chim. Acta, 115: 73–84, 1981.
8.
IwaseH., KimuraP., SugijamaT., MuraiA.: Gas-chromatographic analysis of hypoxanthine and guanine.J. Chromatogr., 106: 213–217, 1975.
9.
JorgensenS., PoulsenH.E.: Enzymatic determination of hypoxanthine and xanthine in human plasma and urine.Acta Pharm. Toxicol., 11: 223–243, 1955.
10.
KitoM., TawaR., TakeshimaS., HiroseS.: Specific simultaneous assay of hypoxanthine and xanthine in serum by reversed-phase high performance liquid chromatography using an immobilized xanthine oxidase reactor.J. Chromatogr., 231: 183–188, 1982.
11.
MiyazakiH., MatsungaY., YoshidaK., ArakawaS., HashimotoM.: Simultaneous determination of plasma and urinary uric acid, xanthine, hypoxanthine, allopurinol, oxypurinol, orotic acid, orotidine and creatinine by high performance liquid chromatography.J. Chromatogr., 274: 76–85, 1983.
PetersenB.B., JorniJ., JorgensenS.: Hypoxanthine, xanthine and uric acid in human urine and in decomposed blood.Scand. J. Clin. Lab. Invest., 17: 454–460, 1965.
14.
PrajdaN., KatunumaN., MorrisH.P., WeberG.: Imbalance of purine metabolism in hepatomas of different growth rates, as expressed in behavior of glutamine phosphoribosyl-pyrophosphate amido transferase (amidophosphoribosyl transferase), (EC 2.4.2.14).Cancer Res., 35: 3061–3068, 1975.
15.
PrajdaN., MorrisH.P., WeberG.: Imbalance of purine metabolism in hepatomas of different growth rates, as expressed in behavior of xantine oxidase, (EC 1.2.3.2).Cancer Res., 36: 4639–4646, 1976.
16.
SalvatoreF., SavoiaM., RussoT., CiminoF.: Modified nucleosides in the biological fluids of tumor-bearing patients.Abstract book Third International Conference on human tumor markers.Lacco Ameno d'Ischia, Naples-Italy, April 23–26, pp. 79–80, 1986.
17.
SimmondsR.J., HarwnessR.A.: High performance liquid chromatographic methods for bases and nucleoside analysis in extracellular fluids and in cells.J. Chromatogr., 226: 369–381, 1981.
18.
WeberG.: Enzymology of cancer cells (first of two parts).N. Engl. J. Med., 296: 486–493, 1977.
19.
WeberG.: Enzymology of cancer cells (second of two parts).N. Engl. J. Med., 296: 541–550, 1977.
20.
WeberG., LuiM.S., TakedaE., DentonJ.E.: Enzymology of human colon tumors.Life Sci., 27: 793–799, 1980.
21.
WeissmanB., BrombergP.A., GutmanA.B.: The purine bases of human urine; semiquantitative estimation and isotope incorporation.J. Biol. Chem., 224: 423–434, 1957.
22.
WheelerG.P., AlexanderJo. A., MorrisH.P.: Synthesis of purines and nucleic acids and catabolism of purines by rat liver and hepatomas. In: Advances in Enzyme Regulation.WeberG. (ed.), vol. 2, pp. 347–369, Pergamon Press, Oxford, London, Edinburgh, New York, Paris, Frankfurt, 1964.
23.
WungW.E., HowellS.B.: Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol and oxypurinol in plasma.Clin. Chem., 26: 1704–1708, 1980.
